Skip to content
Therapies
Use of new peptide as chondrogenesis stimulator and in therapy of cartilage damage
Patent inventors: Piotr Mucha, Izabela Załuska, Sylwia Rodziewicz-Motowidło, Piotr Skowron, Michał Pikuła, Adriana Schumacher, Mirosława Cichorek, Anna Wardowska, Milena Deptuła, Arkadiusz Piotrowski, Natalia Filipowicz, Alina Mieczkowska, Piotr Madanecki, Paweł Sachadyn, Artur Czupryn, Łukasz Janus

A subject of the invention is a novel peptide with chondrogenesis-stimulating activity, especially by stimulating the differentiation of adipose tissue mesenchymal stem cells into chondrocytes and a stimulator of adipose tissue stem cell proliferation, migration and chemotaxis. Also a subject of the invention is the medical use of the peptide as a drug for the treatment of cartilage damage as a chondrogenesis stimulating agent in humans and the in vitro use as a chondrogenesis stimulator, especially a stimulating agent for the differentiation of adipose tissue mesenchymal stem cells into chondrocytes. The delivery application of this invention may provide a new type of therapy for cartilage damage in humans.

Nencki Institute is the co-applicant with University of Gdańsk, Gdańsk University of Technology, Medical University of Gdańsk, MedVentures Sp. z o. o. and ProScience Sp. z o. o. University of Gdańsk is the leader of patent protection and commercialization related activities.

For more information contact Technology Transfer Office.

Application number:
P.431237 (21 Sep 2019)
Patent number:
PL236332 (20 Dec 2020)
Patent status:
granted